Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis
Author:
Publisher
Informa UK Limited
Subject
Immunology,General Medicine,Immunology and Allergy,Rheumatology
Link
http://www.tandfonline.com/doi/pdf/10.1080/03009740601089234
Reference23 articles.
1. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
2. Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
3. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study
4. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor ? monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open-label prospective study
5. Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab;Frontiers in Pharmacology;2023-08-17
2. Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms;Pediatric Rheumatology;2023-06-16
3. Efficacy and safety of immune checkpoint inhibitors and cytokine therapy in autoimmune diseases;Translational Autoimmunity;2022
4. A cross-sectional cohort study of the activity and turnover of neutrophil granulocytes in juvenile idiopathic arthritis;Pediatric Rheumatology;2021-06-30
5. Prediction of clinical effects of infliximab administered for inflammatory bowel disease based on pharmacokinetic and pharmacodynamic modeling;Biopharmaceutics & Drug Disposition;2019-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3